EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Migraine in monogenic disorders: Shedding light on new therapeutic targets

Davide Mascarella iD, Zixuan Alice Zhuang iD, Otilia Gliga, Federico De Santis iD, Chiara Rosignoli, Austeja Daputke iD, Mundih Noelar Njohjam, Elena Mazzotta, Funmilola Eunice Adewinle iD, Edoardo Caronna iD, Patricia Pozo-Rosich iD, International Headache Academy of the International Headache Society (IHS-iHEAD)

Cephalalgia · 2025-10 · 45 (10)

DOI: 10.1177/03331024251389241 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cephalalgia, online erschienen am 28.10.2025. Verfasst von Davide Mascarella und 11 weiteren Autor:innen. Beteiligte Einrichtung: IRRCS Istituto delle Scienze Neurologiche di Bologna, Ausl Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Migraine Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Migraine is a common neurological disorder with a strong genetic component, yet the precise mechanisms underlying its genetic susceptibility remain largely unknown. Genome-wide association studies (GWAS) have identified multiple risk loci, but monogenic forms of migraine, particularly Familial Hemiplegic Migraine (FHM), have provided deeper insights into the pathophysiology of migraine. Studying monogenic disorders that present migraine as a symptom could help identify novel therapeutic targets by uncovering shared molecular pathways.

Methods

A narrative literature review was conducted using a stepwise approach in the PubMed database. Reviewers were divided into three groups, each focusing on different aspects of migraine genetics. The first group analyzed monogenic migraine syndromes, including FHM and related ion-channelopathies. The second group examined clinical manifestations and phenotypic spectrum of FHM-related genes. The third group expanded the search to other monogenic disorders associated with migraine, such as Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), and Familial Advanced Sleep Phase Syndrome (FASPS). Additional searches were conducted using the Compendium of Causative Genes for Monogenic Disorders.

Results

The review identified multiple monogenic disorders associated with migraine, revealing distinct but interconnected mechanisms. Ion-channel dysfunction ( CACNA1A , SCN1A , ATP1A2 ), vascular impairment ( NOTCH3 , TREX1 ), mitochondrial dysfunction ( MT-TL1 ), and circadian dysregulation ( CSNK1D ) emerged as critical contributors to migraine pathophysiology. These findings highlight the roles of neuronal excitability, cortical spreading depression, trigeminal sensitization, and neurovascular dysfunction in migraine.

Conclusions

Monogenic migraine disorders offer valuable insights into migraine pathogenesis, emphasizing the importance of ion homeostasis, vascular function, and circadian regulation. Although genetic studies have not yet directly translated into new therapeutic targets, the study and knowledge of these rare conditions is pivotal for neurologists and migraine specialists, as it might improve diagnosis and care, and provide new insights into migraine pathophysiology that may ultimately inform future treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersHumansGenetic Predisposition to DiseaseGenome-Wide Association Study

Stichwörter der Autor:innen

ATP1A2CACNA1Afamilial hemiplegic migrainegenetic migrainemigrainemonogenic disorders

Autor:innen und Institutionen

  • IRRCS Istituto delle Scienze Neurologiche di Bologna, Ausl Bologna, Bologna, Italy.
  • Department of Biomedical and Neuromotor Sciences DIBINEM, Alma Mater Studiorum Bologna, Bologna, Italy.
  • Department of Neurology, Danish Headache Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Headache Research Group, Vall d'Hebron Institute of Research, Departament de Medicina, Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

ORCID-Profile: Davide Mascarella, Zixuan Alice Zhuang, Federico De Santis, Austeja Daputke, Funmilola Eunice Adewinle, Edoardo Caronna, Patricia Pozo-Rosich

Zitieren

APA

Mascarella, D., Zhuang, Z. A., Gliga, O., Santis, F., Rosignoli, C., Daputke, A., Njohjam, M. N., Mazzotta, E., Adewinle, F. E., Caronna, E., Pozo-Rosich, P., & International Headache Academy of the International Headache Society (IHS-iHEAD) (2025). Migraine in monogenic disorders: Shedding light on new therapeutic targets. Cephalalgia, 45(10). https://doi.org/10.1177/03331024251389241

Vancouver

Mascarella D, Zhuang ZA, Gliga O, Santis F, Rosignoli C, Daputke A, et al. Migraine in monogenic disorders: Shedding light on new therapeutic targets. Cephalalgia. 2025;45(10). doi:10.1177/03331024251389241

BibTeX
@article{Mascarella2025,
  author = {Mascarella, Davide and Zhuang, Zixuan Alice and Gliga, Otilia and Santis, Federico De and Rosignoli, Chiara and Daputke, Austeja and Njohjam, Mundih Noelar and Mazzotta, Elena and Adewinle, Funmilola Eunice and Caronna, Edoardo and Pozo-Rosich, Patricia and International Headache Academy of the International Headache Society (IHS-iHEAD), International Headache Academy of the International Headache Society (IHS-iHEAD)},
  title = {Migraine in monogenic disorders: Shedding light on new therapeutic targets},
  journal = {Cephalalgia},
  year = {2025},
  volume = {45},
  number = {10},
  doi = {10.1177/03331024251389241}
}
Kostenlos starten →